First enrollment in the study expected in Q1 2021 Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world's most advanced total artificial heart, aiming
CARMAT Receives the CE Marking for Its Total Artificial Heart
Virtual press conference scheduled on January 6, 2021
Regulatory News:
CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that it has received the CE marking for its total artificial heart.
The CE marking was granted on December 22, 2020 to CARMAT s total artificial heart system as a bridge to transplant in patients suffering from end-stage biventricular heart failure (Intermacs Classes 1-4) who are not amenable to maximal medical therapy or the LVAD